Machine Learning Model Accurately Diagnoses Celiac Disease
By Elana Gotkine HealthDay Reporter
THURSDAY, April 3, 2025 -- A machine learning algorithm can diagnose celiac disease from duodenal biopsies with accuracy comparable to pathologists, according to a study published online March 27 in the New England Journal of Medicine AI.
Florian Jaeckle, Ph.D., from the University of Cambridge in the United Kingdom, and colleagues developed a novel, accurate, machine learning-based diagnostic classifier to improve celiac disease diagnosis. The model was trained on 3,383 Whole-Slide-Images (WSI) of duodenal biopsies from four hospitals featuring five different WSI scanners and their clinical diagnoses. The model was trained using the multiple instance-learning paradigm in a weakly supervised manner, and it was assessed on an independent test set of 644 unseen scans. The model's predictions were compared to independent diagnoses from four specialist pathologists.
The researchers found that the model diagnosed celiac disease in the independent dataset with accuracy, sensitivity, and specificity exceeding 95 percent and an area under the receiver operating characteristic curve exceeding 99 percent, indicating that the model can potentially outperform pathologists. Comparing the model's predictions with those from independent pathologists, the results were statistically indistinguishable between pathologist-pathologist and pathologist-model interobserver agreement (>96 percent).
"This is the first time artificial intelligence has been shown to diagnose as accurately as an experienced pathologist whether an individual has celiac or not," Jaeckle said in a statement. "Because we trained it on data sets generated under a number of different conditions, we know that it should be able to work in a wide range of settings, where biopsies are processed and imaged differently."
Two authors disclosed ties to the biotechnology research industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Consistent Physical Activity Linked to Reduced All-Cause, CVD Mortality
FRIDAY, July 11, 2025 -- Consistently and increasingly accumulated physical activity (PA) is associated with a reduced risk for all-cause and cardiovascular disease (CVD)...
Increased Liver Enzyme Levels Seen With Use of Cannabidiol in Adults
THURSDAY, July 10, 2025 -- Use of cannabidiol (CBD) within the range consumers are taking with unregulated CBD products is associated with increased liver enzyme levels, according...
Majority of Patients With Lyme Disease Do Not Follow Up With Clinician
THURSDAY, July 10, 2025 -- Only 34 percent of patients with erythema migrans >5 cm are positive for Lyme disease by a standard two-tier testing (STTT) algorithm, and of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.